Open Offer

| Updated on: Dec 16, 2013

HSBC Securities and Capital Markets (India) Private Limited has informed BSE regarding Voluntary Open offer by GlaxoSmithKline Pte Ltd (the "Acquirer") along with GlaxoSmithkline plc in its capacity as person acting in concert (the "PAC") with the Acquirer, to the public shareholders of GlaxoSmithkline Pharmaceuticals Limited (the "Target Company") to acquire 20,609,774 equity shares ("Shares"), pursuant to SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the"Open Offer"). Further, HSBC Securities and Capital Markets (India) Private Limited has also submitted a public announcement which is pursuant to and in compliance with, among others, Regulation 6, Regulation 13(3) and Regulation 15(1) of the SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011 (the "SEBI (SAST) Regulations, 2011").

Source : BSE - www.bseindia.com

Published on December 16, 2013

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you